Viewing Study NCT01168895


Ignite Creation Date: 2025-12-24 @ 2:11 PM
Ignite Modification Date: 2026-02-07 @ 9:59 PM
Study NCT ID: NCT01168895
Status: COMPLETED
Last Update Posted: 2014-04-14
First Post: 2010-07-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study in COPD (Chronic Obstructive Pulmonary Disease) Subjects to Investigate Safety, Tolerability, and Pharmacokinetics of Ciprofloxacin After Single Dose Inhalations of 50 mg and 75 mg Ciprofloxacin Inhalation Powder
Sponsor: Bayer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Infection View
None Pulmonary Disease, Chronic Obstructive View
Keywords:

Keywords

Keyword Brief Keyword Text View
None 75 mg dose strength View
None Safety View
None Pharmacokinetics View